UCLA receives $9.1M from NCI to improve early detection

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $4 million grant from NCI to help advance immune-based therapies to improve treatments and outcomes for people diagnosed with pancreatic ductal adenocarcinoma.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

To help accelerate research into new treatments for acute myeloid leukemia and myelodysplastic syndrome, Thermo Fisher Scientific Inc. is partnering with NCI on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

July 26, 2024

Vol.50 No.30

Clinical Roundup

AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

Unfold AI is better at identifying cancer margins in the prostate than physicians identifying margins by sight, according to a new study. This AI improves accuracy from 67% to 84%, giving physicians more clarity and treatment planning, allowing them to better recommend therapies tailored to each patient.

July 19, 2024

Vol.50 No.29

Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

Linda Liau elected to Taiwan’s Academia Sinica

Linda Liau, chair of neurosurgery at the David Geffen School of Medicine at UCLA, was elected as an Academician of Academia Sinica by the 35th Convocation of Academicians, the preeminent academic institution in Taiwan.

July 12, 2024

Vol.50 No.28

In Brief

UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.8 million grant from NCI to advance their work in personalizing cancer treatment.

July 12, 2024

Vol.50 No.28

UCLA receives $9.1M from NCI to improve early detection

YOU MAY BE INTERESTED IN

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

Linda Liau elected to Taiwan’s Academia Sinica

UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

Renew today!

Subscriber content

Login

UCLA receives $9.1M from NCI to improve early detection

YOU MAY BE INTERESTED IN

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

Linda Liau elected to Taiwan’s Academia Sinica

UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

Login

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”